{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:22:59Z","timestamp":1791894179549,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.acvd.2016.09.009","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:15:20Z","timestamp":1485476120000},"page":"188-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Brugada syndrome: Diagnosis, risk stratification and management"],"prefix":"10.1016","volume":"110","author":[{"given":"Jean-Baptiste","family":"Gourraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Barc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Thollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Le Marec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2016.09.009_bib0285","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0290","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2016.09.009_bib0295","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.acvd.2016.09.009_bib0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2007.07.159","article-title":"Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects","volume":"130","author":"Gallagher","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0305","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.113.001941","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study \u2013 Part 2","volume":"128","author":"Sacher","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2016.09.009_bib0310","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2012.04.013","article-title":"Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome","volume":"9","author":"Sacher","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0315","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2016.03.044","article-title":"Prognostic significance of fever-induced Brugada syndrome","volume":"13","author":"Mizusawa","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0320","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/europace\/eut009","article-title":"Alcohol-induced ventricular fibrillation in a case of Brugada syndrome","volume":"15","author":"Ohkubo","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2016.09.009_bib0325","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2007.10.060","article-title":"Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds","volume":"51","author":"Kusano","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0335","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","article-title":"Proposed diagnostic criteria for the Brugada syndrome: consensus report","volume":"106","author":"Wilde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2016.09.009_bib0340","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.acvd.2010.10.007","article-title":"Ajmaline challenge for the diagnosis of Brugada syndrome: which protocol?","volume":"103","author":"Arnalsteen-Dassonvalle","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2016.09.009_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcvm.2016.00009","article-title":"The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance","volume":"3","author":"Gourraud","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2016.09.009_bib0350","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.hrthm.2004.12.006","article-title":"Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome","volume":"2","author":"Nattel","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0355","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.hrthm.2004.11.025","article-title":"Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome","volume":"2","author":"Wolpert","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.hrthm.2009.01.038","article-title":"Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome","volume":"6","author":"Batchvarov","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0365","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/europace\/eup189","article-title":"Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges","volume":"11","author":"Veltmann","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2016.09.009_bib0370","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2006.07.062","article-title":"Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome","volume":"99","author":"Miyamoto","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0375","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehr129","article-title":"The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern","volume":"32","author":"Sarkozy","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2016.09.009_bib0380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jelectrocard.2005.06.005","article-title":"Acquired forms of the Brugada syndrome","volume":"38","author":"Shimizu","year":"2005","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0385","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/europace\/euv278","article-title":"Expert cardiologists cannot distinguish between Brugada phenocopy and Brugada syndrome electrocardiogram patterns","volume":"18","author":"Gottschalk","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2016.09.009_bib0390","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/cvr\/cvv042","article-title":"Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study","volume":"106","author":"Behr","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.acvd.2016.09.009_bib0395","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/hmg\/ddv036","article-title":"Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome","volume":"24","author":"Le Scouarnec","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.acvd.2016.09.009_bib0400","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.acvd.2016.09.009_bib0405","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.acvd.2013.04.007","article-title":"Dual phenotypic transmission in Brugada syndrome","volume":"106","author":"Hermida","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2016.09.009_bib0410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","article-title":"Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing","volume":"13","author":"Adler","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15420\/aer.2012.1.17","article-title":"Risk stratification and therapeutic approach in Brugada syndrome","volume":"1","author":"Probst","year":"2012","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.acvd.2016.09.009_bib0420","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2014.10.014","article-title":"Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes","volume":"12","author":"Olde Nordkamp","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2016.09.009_bib0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1540-8167.2008.01282.x","article-title":"Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome","volume":"20","author":"Richter","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0435","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jelectrocard.2010.06.011","article-title":"Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome","volume":"43","author":"Extramiana","year":"2010","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0440","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2008.07.052","article-title":"Gender differences in clinical manifestations of Brugada syndrome","volume":"52","author":"Benito","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0445","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/heartjnl-2015-308556","article-title":"Clinical characterisation and long-term prognosis of women with Brugada syndrome","volume":"102","author":"Sieira","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2016.09.009_bib0450","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.hrthm.2016.02.013","article-title":"Impact of clinical and genetic findings on the management of young patients with Brugada syndrome","volume":"13","author":"Andorin","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0455","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jama.2014.13752","article-title":"Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms","volume":"312","author":"Conte","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2016.09.009_bib0460","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.jacc.2014.02.574","article-title":"Drug-induced Brugada syndrome in children: clinical features, device-based management, and long-term follow-up","volume":"63","author":"Conte","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0465","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jce.12359","article-title":"Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome","volume":"25","author":"Conte","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0470","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2016.01.024","article-title":"A new electrocardiographic marker of sudden death in brugada syndrome: the S-wave in lead I","volume":"67","author":"Calo","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0475","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCEP.108.816892","article-title":"Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1\u2013V3","volume":"2","author":"Kamakura","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0480","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.108.770917","article-title":"Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome","volume":"118","author":"Morita","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2016.09.009_bib0485","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.jacc.2014.01.072","article-title":"Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities","volume":"63","author":"Tokioka","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0490","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1253\/circj.66.1101","article-title":"Prolongation of LAS40 (duration of the low amplitude electric potential component (<40 microV) of the terminal portion of the QRS) induced by isoproterenol in 11 patients with Brugada syndrome","volume":"66","author":"Takagi","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.acvd.2016.09.009_bib0495","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hrthm.2007.04.017","article-title":"aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome","volume":"4","author":"Babai Bigi","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0500","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.amjcard.2013.06.033","article-title":"Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome","volume":"112","author":"Maury","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0505","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCEP.108.795153","article-title":"Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome","volume":"2","author":"Sarkozy","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0510","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.hrthm.2008.09.021","article-title":"Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome","volume":"5","author":"Letsas","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0515","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2013.03.001","article-title":"Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome","volume":"10","author":"Rollin","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0520","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.hrthm.2015.07.029","article-title":"Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome","volume":"12","author":"Maury","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2016.09.009_bib0525","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1540-8167.2007.01050.x","article-title":"Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients","volume":"19","author":"Junttila","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0530","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1540-8167.2003.02517.x","article-title":"Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart","volume":"14","author":"Brugada","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0535","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.ijcard.2013.04.146","article-title":"Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta-analysis of worldwide published data","volume":"168","author":"Fauchier","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0540","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2016.09.009_bib0545","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/europace\/eut279","article-title":"Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine","volume":"16","author":"Bouzeman","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2016.09.009_bib0550","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCEP.115.003576","article-title":"Quinidine in Brugada syndrome: still a long way to go","volume":"8","author":"Probst","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.acvd.2016.09.009_bib0555","first-page":"225","article-title":"QUIDAM Study: assessment of hydroquinidine therapy in the management of Brugada syndrome patients at high arrhythmic risk and implanted with an ICD","volume":"8","author":"Andorin","year":"2016","journal-title":"ACVD Suppl"},{"key":"10.1016\/j.acvd.2016.09.009_bib0560","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2010.06.033","article-title":"Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome","volume":"56","author":"Makimoto","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213617300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213617300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:43:57Z","timestamp":1761745437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213617300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1875213617300013"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2016.09.009","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brugada syndrome: Diagnosis, risk stratification and management","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}